Literature DB >> 25370355

Clinical spectrum of impulse control disorders in Parkinson's disease.

Daniel Weintraub1, Anthony S David, Andrew H Evans, Jon E Grant, Mark Stacy.   

Abstract

Impulse control disorders (ICDs), including compulsive gambling, buying, sexual behavior, and eating, are a serious and increasingly recognized psychiatric complication in Parkinson's disease (PD). Other impulsive-compulsive behaviors (ICBs) have been described in PD, including punding (stereotyped, repetitive, purposeless behaviors) and dopamine dysregulation syndrome (DDS; compulsive PD medication overuse). ICDs have been most closely related to the use of dopamine agonists (DAs), perhaps more so at higher doses; in contrast, DDS is primarily associated with shorter-acting, higher-potency dopaminergic medications, such as apomorphine and levodopa. Possible risk factors for ICDs include male sex, younger age and younger age at PD onset, a pre-PD history of ICDs, and a personal or family history of substance abuse, bipolar disorder, or gambling problems. Given the paucity of treatment options and potentially serious consequences, it is critical for PD patients to be monitored closely for development of ICDs as part of routine clinical care.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; dopamine agonists; impulse control disorder

Mesh:

Substances:

Year:  2014        PMID: 25370355     DOI: 10.1002/mds.26016

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  86 in total

1.  The changing tree in Parkinson's disease.

Authors:  Paolo Calabresi; Massimiliano Di Filippo
Journal:  Nat Neurosci       Date:  2015-09       Impact factor: 24.884

Review 2.  Modern treatment in Parkinson's disease, a personal approach.

Authors:  Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-21       Impact factor: 3.575

Review 3.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

4.  Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.

Authors:  F Imperiale; F Agosta; E Canu; V Markovic; A Inuggi; M Jecmenica-Lukic; A Tomic; M Copetti; S Basaia; V S Kostic; M Filippi
Journal:  Mol Psychiatry       Date:  2017-03-07       Impact factor: 15.992

5.  Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.

Authors:  Kalen Petersen; Nelleke Van Wouwe; Adam Stark; Ya-Chen Lin; Hakmook Kang; Paula Trujillo-Diaz; Robert Kessler; David Zald; Manus J Donahue; Daniel O Claassen
Journal:  Hum Brain Mapp       Date:  2017-10-31       Impact factor: 5.038

Review 6.  Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders.

Authors:  Marjan Jahanshahi; John C Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

Review 7.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

8.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 9.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 10.  Dementia, Decision Making, and Capacity.

Authors:  R Ryan Darby; Bradford C Dickerson
Journal:  Harv Rev Psychiatry       Date:  2017 Nov/Dec       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.